Chip names led a broad midday move in U.S. equities, with semiconductors among the few groups delivering gains as investors rotated away from software exposure. According to CNBC, Marvell Technology surged nearly 7%, Broadcom added about 4%, and AMD rose around 3%, helping the VanEck Semiconductor ETF to climb roughly 1.7%. The session underscored ongoing appetite for hardware assets amid AI-driven demand signals.
In a separate burst of activity, Organon spiked about 24% after Economic Times reports that Sun Pharmaceutical Industries is considering a roughly $12 billion offer for the New Jersey-based women’s-health company. Sun Pharma characterized the story as speculative in nature and declined further comment. The move reflected a potential reshaping of Organon’s strategic ownership, though no formal bid has been announced.
Texas Pacific Land also moved higher, up about 9% on the day, a day after Horizon Kinetics’ chief executive officer Murray Stahl’s death triggered a broad retreat in the stock the prior session. Horizon Kinetics is the largest shareholder of Texas Pacific Land, and Stahl sat on TPL’s board, linking the two moves in investors’ minds.
Palantir Technologies traded off its intraday lows after President Donald Trump highlighted the software company in a Truth Social post, praising its capabilities. Even so, Palantir still faced a weekly decline of close to 14% as the session progressed, with shares down about 2% on the day.
Cybersecurity stocks resumed pressure as concerns over AI’s potential to disrupt cyber infrastructures weighed on margins and business models. Akamai Technologies fell more than 13%, while Palo Alto Networks slid over 6%, Zscaler slipped about 3%, and CrowdStrike declined roughly 4%. The sector’s risk-off tone reflected lingering fears about the pace of AI-related disruption and the intensity of competitive pressure.
Coherent, a maker of photonics systems, gained about 7% after analysts this week issued favorable notes. JPMorgan boosted its price target to 300 from 245 and reiterated an overweight rating, contributing to the stock’s outperformance in an AI-enabled rally for optics and related hardware.
ServiceNow moved lower, down about 7% after UBS downgraded the software provider from buy to neutral. UBS had previously argued that ServiceNow was relatively well positioned to navigate the AI era, but its confidence in that view appeared to weaken on the latest assessment.
Taiwan Semiconductor Manufacturing Co. (TSMC) rose about 2% after reporting record first-quarter revenue. Revenue rose 35% year over year to 1.13 trillion New Taiwan dollars, roughly $35.6 billion, underscoring robust demand in the company’s foundry business amid a global chip-upcycle backdrop.
CoreWeave also charged higher, lifting more than 12% after announcing a multi-year compute agreement with Anthropic to support the Claude model. The deal positions CoreWeave to supply compute resources as Anthropic scales its AI software in the coming quarters, with elements of the deployment set to come online later this year.
Key takeaways
- Price move: Chipmakers led gains, with Marvell nearly 7% higher and the semiconductor index rising as the sector captured renewed interest from investors.
- Catalyst: Reports of a potential $12 billion bid for Organon spurred a sharp jump in the drug maker, while AI-related spending and AI-model deployment lifted select AI-enabled hardware players.
- Key implication: The day’s action points to a continued rotation into semiconductors and AI infrastructure plays, even as cybersecurity names remain under pressure amid AI-inflamed risk concerns.
What drove the move
The core driver appears to be sector rotation into semiconductors and AI-enabled infrastructure. A day of headlines around potential M&A activity in health care stock Organon added a separate source of volatility, illustrating investors’ willingness to chase value on policy and deal chatter. Within chips, investors appear to be pricing in ongoing demand for both mature and next-generation compute capacities as AI workloads scale globally, contributing to a more favorable backdrop for hardware suppliers in the near term.
Market reaction
Equities reflected a mixed mood: strength in chip suppliers and select AI compute names contrasted with meaningful pressure in cybersecurity and several software-oriented equities. The shifts suggest investors are differentiating between hardware exposure tied to AI adoption and software platforms that face more uncertain near-term dynamics as AI competition intensifies.
What analysts are saying
Analysts highlighted a few notable calls shaping sentiment. JPMorgan publicly raised its price target on Coherent to $300 from $245 while maintaining an overweight stance, underscoring a constructive view on AI-enabled photonics suppliers. On the flipside, UBS downgraded ServiceNow to neutral, signaling a reassessment of valuation and growth trajectories for certain enterprise software peers even as some were previously viewed as AI beneficiaries. Separately, Sun Pharmaceutical’s response to Organon’s potential sale discussed above reflected typical investor caution around speculative M&A chatter in health care stocks.
Bigger picture
The session sits within a broader macro backdrop where AI-driven demand continues to influence capital allocation. Semiconductor and AI-infrastructure names have shown resilience in various risk-on environments, even as pockets of the tech complex remain volatile. The health care M&A window—illustrated by Organon’s trading on speculation—adds another layer of sensitivity to deal flow and strategic repositioning across sectors. Investors will be watching how AI adoption rates translate into earnings trajectories for hardware suppliers and whether sentiment eases for software players that have faced multiple waves of AI-related re-rating.
What to watch next: upcoming earnings reports and guidance from technology and chip companies, further commentary on AI deployment and pricing power, and any fresh developments around Organon and Sun Pharmaceutical. Market participants will also be focusing on macro data and central bank commentary for clues on the path of rates, which could influence the appetite for cyclical tech exposure.
